DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Van Rompaey L, Galien R, van der Aar EM. et al.
Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the
treatment of inflammatory diseases.
J Immunol 2013;
191: 3568-3577
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.